Skip to main content
Premium Trial:

Request an Annual Quote

Shareholders OK Genome Therapeutics, Genesoft Merger

NEW YORK, Feb. 2 (GenomeWeb News) - Genome Therapeutics and Genesoft Pharmaceuticals said today that their shareholders approved the proposed merger of the two companies at two separate special meetings.


The companies said that they expect to close the transaction "as soon as practicable," but noted that the deal is still subject to certain conditions including the raising of $32 million to fund the combined entity.


The all-stock merger was first announced in November. The US Securities and Exchange Commission cleared a registration statement related to the merger in late December.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.